Drugs / NETA
last change Feb 2021 re-read 2 minutes ago

NETA

Developed for
endometriosis
Investigated by
Kissei Pharmaceutical Co., Ltd.

Trials 1 · a red edge is where a trial was stopped

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04372121 Mar 2020 → Jan 2021 endometriosis Kissei Pharmaceutical Co., Ltd. Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as NETA ClinicalTrials.gov intervention name — accepted as the source's own label NCT04372121